Specifications Table {#s0005}
====================

TableSubject area*Cardiac arrest, clinical evidence*More specific subject area*The utility of end-tidal carbon dioxide measurement as it correlates with return of spontaneous circulation (ROSC) or survival in adults experiencing cardiac arrest in any setting.*Type of data*Table, Figures*How data was acquired*Review of primary articles pertaining to end-tidal carbon dioxide measurement as it correlates with return of spontaneous circulation (ROSC) or survival in adults experiencing cardiac arrest in any setting.*Data format*Analyzed data*Experimental factors*Description of the published literature on end-tidal carbon dioxide measurement as it correlates with return of spontaneous circulation (ROSC) or survival in adults experiencing cardiac arrest in any setting.*Experimental features*Systematic review*Data source location*Original English-language articles identified from search of Embase, MEDLINE, and Cochrane Databases.*Data accessibility*Data are available with this article*

Value of the data {#s0010}
=================

•These data describe evidence available in the English-language medical literature pertaining to end-tidal carbon dioxide measurement as it correlates with return of spontaneous circulation (ROSC) or survival to hospital discharge in adult patients experiencing cardiac arrest in any setting.•These data allow other researchers to extend the statistical analyses.

1. Data {#s0015}
=======

These data report findings determined through the 2015 Consensus on Science and Treatment Recommendations process, managed by the International Liaison Committee on Resuscitation ([www.ilcor.org/seers](http://www.ilcor.org/seers){#ir0005}). These data include those studies that were considered to be most relevant in the determination of the utility of end-tidal carbon dioxide (ETCO2) measurement in the management of cardiac arrest in any setting. These data have been reported as the results of this effort to describe the use of ETCO2 in adult cardiac arrest, and are provided in a summary article describing their utility for adult patient experiencing cardiac arrest in any clinical setting [@bib1]. A total of 17 full-text articles were included in the qualitative synthesis [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], and 5 articles were included in the quantitative analysis [@bib3], [@bib4], [@bib5], [@bib6], [@bib7]. [Fig. 1](#f0005){ref-type="fig"} shows a flow diagram of search results, including those full-text articles that were included in the qualitative synthesis and the quantitative analysis. [Fig. 2](#f0010){ref-type="fig"} shows a Forest plot of the correlation between ETCO~2~ and ROSC. [Fig. 3](#f0015){ref-type="fig"} shows a Forest plot of the correlation between specific ETCO~2~ levels and survival to hospital discharge. [Table 1](#t0005){ref-type="table"} shows the characteristics of the included studies. [Table 2](#t0010){ref-type="table"} shows a summary of findings, including ETCO~2~ level higher or lower than 10- or 20-mmHg for predicting outcome following cardiac arrest.Fig. 1Flow diagram of search results.Fig. 1Fig. 2Forest plot of the correlation between ETCO~2~ and ROSC: A. Initial ETCO~2~ ≥ 10 mmHg; B. Initial ETCO~2~ ≥ 20 mmHg; C. 20-min ETCO~2~ ≥ 10 mmHg; D. 20-min ETCO~2~ ≥ 20 mmHg.Fig. 2Fig. 3Forest plot of the correlation between specific ETCO~2~ levels and survival to hospital discharge: A. Initial ETCO~2~ ≥ 10 mmHg; B. Initial ETCO~2~ ≥ 20 mmHg; C. 20-min ETCO~2~ ≥ 10 mmHg; D. 20-min ETCO~2~ ≥ 20 mmHg.Fig. 3Table 1Characteristics of the included studies.Table**Study yearDesign*****N*****PopulationVF/VT (%)Asystole/PEA (%)ETCO**~**2**~**measurementTime of ETCO**~**2**~**measurement (cut-off, mmHg)Outcome(s)ResultsPotential biasIncluded in meta-analysisROSC/Survival**Ahrens 2001Prospective cohort127IHCA and Helicopter76.024.0[a](#tbl1fna){ref-type="table-fn"}CapnographyInitial, 5, 10, 15, 20 min, and final (≥ 10 and ≥ 20)ROSCETCO~2~ ≥ 20 mmHg at 5 and 10 min -- 94.4% of survivalConvenience sampling 14% have already achieved ROSCYes43% ROSC31.5% STFHSTFHETCO~2~ ≤ 17.5 mmHg at 15 min -- 91.9% of non-survival13.7% SHDSHD                          Callaham 1990Prospective cohort55OHCA10.954.5/34.6CapnometryInitial (≥ 10 and ≥ 20)ROSCETCO~2~ ≥ 15 mmHg predicted ROSC (sensitivity 71% and specificity of 98%)Rescuers not blindedYes25.5% ROSCSmall number of patients  Cantineau 1996Prospective cohort120OHCA6.390.6/3.1CapnometryInitial and maximum (≥ 10)ROSCETCO~2~ ≥ 10 mmHg predicted ROSC (sensitivity 87% and specificity of 74%)90.6% asystoleYes31.7% ROSC                          Wayne 1995Prospective cohort90OHCA0.00.0/100.0Capnography20 min (≥ 10)ROSCETCO~2~ ≥ 10 mmHg predicted ROSC (sensitivity 97.3% and specificity 100.0%)Only PEAYes17.8% ROSCSHA14.4% SHASHD7.8% SHD                          Levine 1997Prospective cohort150OHCA0.00.0/100.0Capnography20 min (≥ 10)ROSCETCO~2~ ≤ 10 mmHg predicted non-survival (sensitivity 100% and specificity of 100%)Only PEA Includes data from Wayne\'s studyYes23.3% ROSCSHD10.7% SHD                          Sanders 1989Prospective cohort35IHCA47.327.1/25.6CapnometryAverage (≥ 10)ROSCAll patients with ROSC had average ETCO~2~ ≥ 10 mmHgSmall number of patientsNo25.7% ROSCSHD8.6% SHD                          Salen 2001Prospective cohort53IHCA0.00.0/100.0CapnographyInitial (≥ 16)SHAETCO~2~ ≥ 16 mmHg associated with survival to admissionConvenience samplingNo11.3% SHASmall number of patients  Eckstein 2011Retrospective cohort3121OHCA16.9NACapnographyInitial (≥ 10 and ≥ 20)ROSCETCO~2~ ≥ 10 mmHg associated with ROSC (OR 4.79; 95% CI 3.10 to 4.42)[c](#tbl1fnc){ref-type="table-fn"}Retrospective large study, but an unreliable OR is providedNo22.4% ROSCAsplin 1995Prospective cohort27OHCA48.2NACapnography1 and 2 min (No specific cut-off)ROSCHigher ETCO~2~ levels in ROSC vs. non-ROSC (23.0 vs. 13.2 at 1 min, 26.8 vs. 15.4 at 2 min)Convenience samplingNo51.9% ROSCSHDSmall number of patients11.1% SHD                          Grmec 2001Prospective cohort139OHCA40.351.8/7.9CapnometryInitial, final and average (≥ 10)ROSCETCO~2~ ≥ 10 mmHg predicted ROSC (sensitivity 100.0% and specificity of 74.1%, 81.4%, and 90.0%, respectively for initial, average, and final ETCO~2~)--No38.1% ROSCSHD16.6% SHD                          Grmec 2003Prospective cohort185OHCA76.223.8[b](#tbl1fnb){ref-type="table-fn"}CapnometryInitial, final and average (≥ 10)ROSCAverage and final ETCO~2~ higher in ROSC patients. Initial ETCO~2~ higher in ROSC patients only if cardiac originIncludes data from Grmec 2001No64.3% ROSCSID24.3% SID                          Grmec 2007Prospective cohort389OHCA40.140.9/19.0CapnometryInitial, final and average (≥ 10)ROSCInitial ETCO~2~ ≥ 10 mmHg associated with ROSCIncludes data from Grmec 2003No60.9% ROSCSHA50.1% SHASHD21.1% SHD                          Heradstveit 2012Retrospective cohort575OHCA34.446.3/19.3CapnographyAverage, minimum and maximum (No specific cut-off)ROSCETCO~2~ higher in ROSC patientsRetrospectiveNo49.7% ROSCSHA40.4% SHA                          Kolar 2008Retrospective cohort737OHCA41.238.4/20.4Capnometry20 min (≥ 14.3)ROSCETCO~2~ ≥ 14.3 mmHg predicted ROSC (sensitivity 100% and specificity 100%),Retrospective Includes data from Grmec 2001, 2003, and 2007No59.4% ROSCSHA54.6% SHASHD23.1% SHD                          Lah 2011Prospective cohort114OHCA55.344.7[b](#tbl1fnb){ref-type="table-fn"}CapnometryInitial and every 1 min (No specific cut-off)ROSCHigher initial ETCO~2~ for those with ROSC if primary cardiac arrest (34.6 vs. 24.7 mmHg)Comparison between asphyxial and cardiac origin of the arrestNo63.2% ROSCSID52.6% SIDSHD29.8% SHD                          Mauer 1998Prospective cohort120OHCA49.117.9/33.0CapnometryInitial and every 2 min (≥ 15.0)ROSCAll admitted patients had an ETCO~2~ ≥ 15 mmHgETCO~2~ was a secondary endpointNo57.5% ROSCSHA27.5% SHASHD10.8% SHD                          Rognås 2014Prospective cohort271OHCANANACapnographyInitial (≥ 10)ROSC4/22 patients with ETCO~2~ ≤ 10 mmHg had ROSC.23% lacking measurementsNo4 of 22 patients (18.2%) had ROSC with ETCO~2~ ≤ 1.3 kPaNo specific cut-off should be used during resuscitation[^1][^2][^3][^4]Table 2Summary of findings: ETCO~2~ higher vs. ETCO~2~ lower than 10 or 20 mmHg for predicting outcome following cardiac arrest.Table 2**Quality assessmentNo. of patientsEffectQualityImportanceNo. of studiesStudy designRisk of biasInconsistencyIndirectnessImprecisionOther considerationsETCO**~**2**~**higherETCO**~**2**~**lowerRelative (95% CI)Absolute (95% CI)ROSC (Initial ETCO**~**2**~** ≥ 10 vs. \< 10 mmHg)**3[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}^,^[c](#tbl2fnc){ref-type="table-fn"}observational studiesserious[d](#tbl2fnd){ref-type="table-fn"}not seriousnot seriousnot seriousvery strong association80/134 (59.7%)16/140 (11.4%)OR 10.7 (5.6--20.3)483 more per 1000 (from 326 more to 620 more)LOWCRITICALdose response gradient**ROSC (Initial ETCO**~**2**~** ≥ 20 vs. \< 20** **mmHg)**2[a](#tbl2fna){ref-type="table-fn"}^,^[b](#tbl2fnb){ref-type="table-fn"}observational studiesserious[d](#tbl2fnd){ref-type="table-fn"}^,^[e](#tbl2fne){ref-type="table-fn"}not seriousnot seriousnot seriousvery strong association34/42 (81.0%)32/136 (23.5%)OR 12.2 (5.1--29.2)574 more per 1000 (from 406 more to 675 more)LOWCRITICAL**ROSC (20 min ETCO**~**2**~** ≥ 10 vs. \< 10 mmHg)**3[a](#tbl2fna){ref-type="table-fn"}^,^[f](#tbl2fnf){ref-type="table-fn"}^,^[g](#tbl2fng){ref-type="table-fn"}observational studiesvery serious[d](#tbl2fnd){ref-type="table-fn"}^,^[h](#tbl2fnh){ref-type="table-fn"}serious[i](#tbl2fni){ref-type="table-fn"}not seriousnot seriousvery strong association64/79 (81.0%)1/215 (0.5%)OR 181.6 (40.1--822.6)805 more per 1000 (from 351 more to 966 more)LOWCRITICALall plausible residual confounding would reduce the demonstrated effect**ROSC (20 min ETCO**~**2**~** ≥ 20 vs. \< 20 mmHg)**1[a](#tbl2fna){ref-type="table-fn"}observational studyserious[d](#tbl2fnd){ref-type="table-fn"}not seriousnot seriousnot seriousvery strong association12/13 (92.3%)2/41 (4.9%)OR 234,0 (19.5--2811.4)874 more per 1000 (from 451 more to 944 more)LOWCRITICAL**Survival at discharge (Initial ETCO**~**2**~** ≥ 10 vs. \< 10 mmHg)**1[a](#tbl2fna){ref-type="table-fn"}observational studyserious[d](#tbl2fnd){ref-type="table-fn"}not seriousnot seriousnot seriousvery strong association14/68 (20.6%)1/45 (2.2%)OR 11.4 (1.4--90.2)184 more per 1000 (from 9 more to 650 more)LOWCRITICAL**Survival at discharge (Initial ETCO**~**2**~** ≥ 20 vs. \< 20 mmHg)**1[a](#tbl2fna){ref-type="table-fn"}observational studyserious[d](#tbl2fnd){ref-type="table-fn"}not seriousnot seriousnot seriousvery strong association12/34 (35.3%)3/79 (3.8%)OR 13.8 (3.6--53.4)315 more per 1000 (from 86 more to 640 more)LOWCRITICAL**Survival at discharge (20 min ETCO**~**2**~** ≥ 10 vs. \< 10 mmHg)**1[a](#tbl2fna){ref-type="table-fn"}observational studyserious[d](#tbl2fnd){ref-type="table-fn"}not seriousnot seriousserious[j](#tbl2fnj){ref-type="table-fn"}none4/25 (16.0%)1/28 (3.6%)OR 5.1 (0.5--49.5)123 more per 1000 (from 18 fewer to 611 more)VERY LOWCRITICAL**Survival at discharge (20 min ETCO**~**2**~** ≥ 20 vs. \< 20 mmHg)**1[a](#tbl2fna){ref-type="table-fn"}observational studyserious[d](#tbl2fnd){ref-type="table-fn"}not seriousnot seriousnot seriousvery strong association4/12 (33.3%)1/41 (2.4%)OR 20,0 (2.0--203.3)309 more per 1000 (from 23 more to 811 more)LOWCRITICAL[^5][^6][^7][^8][^9][^10][^11][^12][^13][^14][^15]

2. Experimental design, materials and methods {#s0020}
=============================================

This review includes information on resuscitation questions developed through the 2015 Consensus on Science and Treatment Recommendations (CoSTR) development process, managed by the International Liaison Committee on Resuscitation (ILCOR) [@bib19]. The questions were developed by ILCOR Task Force members, utilizing strict conflict of interest guidelines [@bib20]. In general, each question was assigned to two experts to complete a detailed structured review of the literature, and complete a detailed evidence evaluation. Evidence evaluations are discussed at ILCOR meetings to reach consensus prior to publication as the Consensus on Science and Treatment Recommendations [@bib19], [@bib20], [@bib21], [@bib22].

Transparency document. Supplementary material {#s0030}
=============================================

Supplementary material

This review includes information on cardiac arrest resuscitation questions developed through the 2015 CoSTR process, managed by the International Liaison Committee on Resuscitation ([www.ilcor.org/seers](http://www.ilcor.org/seers){#ir0010}). No additional funding or financial support was received by the investigators to perform this review.

Transparency data associated with this article can be found in the online version at [doi:10.1016/j.dib.2018.04.075](https://doi.org/10.1016/j.dib.2018.04.075){#ir0015}.

[^1]: ETCO~2~, end-tidal CO~2~; NA, not available; IHCA, in-hospital cardiac arrest; OHCA, out-of-hospital cardiac arrest; OR, odds ratio; PEA, pulseless electrical activity; ROSC, return of spontaneous circulation; VF, ventricular fibrillation; VT, ventricular tachycardia; ROSC, return of spontaneous circulation; STFH, survival to twenty-four hours following cardiac arrest; SHA, survival to hospital admission; SID, survival to intensive care unit discharge; SHD, survival to hospital discharge.

[^2]: Includes asystole, PEA, and 14% in supraventricular tachycardia with a pulse, after intubation and first ETCO~2~ measurement.

[^3]: Includes asystole and PEA.

[^4]: Upper limit of confidence interval lower than OR.

[^5]: All observational studies start with low quality ratings, and we have decided not to downgrade on risk of bias because of the very strong association between higher ETCO~2~ levels and ROSC or survival at discharge.

[^6]: Ahrens [@bib3].

[^7]: Callaham [@bib4].

[^8]: Cantineau [@bib5].

[^9]: Convenience sampling, with 14% having already achieved ROSC.

[^10]: Small number of patients.

[^11]: Levine [@bib7].

[^12]: Wayne [@bib6].

[^13]: Includes data from previous study.

[^14]: high heterogeneity (*I*^2^ = 78%).

[^15]: Large confidence interval that crosses 1.0.
